IvWatch develops an intravenous infiltration detector that is a self-contained unit consisting of an electronic device and a skin sensor.
ivWatch has raised $13.7M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in February 2022.
ivWatch is headquartered in Newport News, United States.
IvWatch develops an intravenous infiltration detector that is a self-contained unit consisting of an electronic device and a skin sensor.
ivWatch is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"ivWatch — Funding & Investors." VCBacked, February 10, 2022, https://www.vcbacked.co/company/ivwatch. Accessed August 16, 2026.
VCBacked. (2022). ivWatch — Funding & Investors. Retrieved August 16, 2026, from https://www.vcbacked.co/company/ivwatch
{{cite web |title=ivWatch — Funding & Investors |url=https://www.vcbacked.co/company/ivwatch |website=VCBacked |access-date=August 16, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated